PACS Group Inc (PACS) concluded trading on Wednesday at a closing price of $13.20, with 0.49 million shares of worth about $6.4 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -56.26% during that period and on January 08, 2025 the price saw a loss of about -0.45%. Currently the company’s common shares owned by public are about 152.40M shares, out of which, 37.97M shares are available for trading.
Stock saw a price change of 0.69% in past 5 days and over the past one month there was a price change of -14.89%. Over the period of past 52 weeks, stock dropped to lowest price of $12.54 but also hit the highest price of $43.92 during that period. The average intraday trading volume for PACS Group Inc shares is 1.46 million. The stock is currently trading -3.39% below its 20-day simple moving average (SMA20), while that difference is down -30.22% for SMA50 and it goes to -55.14% lower than SMA200.
PACS Group Inc (NYSE: PACS) currently have 152.40M outstanding shares and institutions hold larger chunk of about 32.15% of that.
The stock has a current market capitalization of $2.05B. It has Quick Ratio of 1.71 while making debt-to-equity ratio of 4.74. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PACS, volatility over the week remained 5.66% while standing at 5.35% over the month.
Stock’s fiscal year EPS is expected to rise by 70.67% while it is estimated to increase by 21.49% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by JP Morgan on December 17, 2024 offering a Neutral rating for the stock and assigned a target price of $18 to it. Coverage by JP Morgan stated PACS Group Inc (PACS) stock as an Overweight in their note to investors on November 06, 2024, suggesting a price target of $40 for the stock. On October 09, 2024, UBS Initiated their recommendations, while on September 11, 2024, Citigroup Resumed their ratings for the stock with a price target of $45. Stock get an Outperform rating from Macquarie on June 28, 2024.
